Australia's largest stock trading and investment forum Australia's #1 stock forum

MDC

Click for more information

0.00%

$6.60 medlab clinical limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-29

First 29 Last

Share
Profile

Follow
Deb_R

161 Posts.

27

04/11/22

06:44

Post #: 64581067
Share

Originally posted by Apse: ↑

- NanaBis is completely built on the NanoCelle delivery platform, which is the key differentiator over every other cannabinoid product or company seeking regulatory approvals globally.

- Validating NanoCelle through an FDA approved drug (NanaBis) literally *is* their core business and a major way they will generate huge concrete revenues through immediate sales and lock down big pharma partnerships on NanoCelle.

- Based on precedents such as GW Pharma's Epidiolex, or even Sativex (which I suspect was the drug NanaBis has already blown out of the water in independent testing) an FDA approval will be immensely profitable (~US$500m+ YR1 sales).

If anything, by divesting the VMS business, cutting costs and locking down funds through a Nasdaq listing, Medlab seem to be extremely focussed on their core business objectives.

Expand

how much nanabis has been sold through SAS scheme?

MDC Price at posting: $10.00 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

Making money: How many microcaps should be in an investor's portfolio?

There are more pages in this discussion • 27 more messages in this thread...

First 29 Last

Add MDC (ASX) to my watchlist